Hempel Karsten, McDonald Wade, Osgood Nathaniel D, Fisman David, Halperin Scott A, Crowcroft Natasha, Klein Nicola P, Rohani Pejman, Doroshenko Alexander
Department of Medicine, Division of Preventive Medicine, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Department of Computer Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Vaccine. 2023 Apr 6;41(15):2430-2438. doi: 10.1016/j.vaccine.2022.12.071. Epub 2023 Feb 10.
The re-emergence of pertussis has occurred in the past two decades in developed countries. The highest morbidity and mortality is seen among infants. Vaccination in pregnancy is recommended to reduce the pertussis burden in infants.
We developed and validated an agent-based model to characterize pertussis epidemiology in Alberta. We computed programmatic effectiveness of pertussis vaccination during pregnancy (PVE) in relation to maternal vaccine coverage and pertussis disease reporting thresholds. We estimated the population preventable fraction (PFP) of different levels of maternal vaccine coverage against counterfactual "no-vaccination" scenario. We modeled the effect of immunological blunting and measured protection through interruption of exposure pathways.
PVE was inversely related to duration of passive immunity from maternal immunization across most simulations. In the scenario of 50% maternal vaccine coverage, PVE was 87% (95% quantiles 82-91%), with PFP of 44% (95% quantiles 41-45%). For monthly age intervals of 0-2, 2-4, 4-6 and 6-12, PVE ranged between 82 and 99%, and PFP ranged between 41 and 49%. At 75% maternal vaccine coverage, PVE and PFP were 90% (95% quantiles 86-92%) and 68% (95% quantiles 65-69%), respectively. At 50% maternal vaccine coverage and 10% blunting, PVE and PFP were 86% (95% quantiles 77-87%) and 43% (95% quantiles 39-44%), respectively, while at 50% blunting, the corresponding values of PVE and PFP were 76% (95% quantiles 70-81%) and 38% (95% quantiles 35-40%). PVE attributable to interruption of exposure pathways was 54-57%.
Our model predicts significant reduction in future pertussis cases in infants due to maternal vaccination, with immunological blunting slightly moderating its effectiveness. The model is most sensitive to maternal vaccination coverage. The interruption of exposure pathways plays a role in the reduction of pertussis burden in infants due to maternal immunization. The effect of maternal immunization on population other than infants remains to be elucidated.
在过去二十年中,百日咳在发达国家再度出现。发病率和死亡率最高的是婴儿。建议在孕期接种疫苗以减轻婴儿的百日咳负担。
我们开发并验证了一个基于主体的模型,以描述艾伯塔省的百日咳流行病学特征。我们计算了孕期百日咳疫苗接种(PVE)相对于孕产妇疫苗接种覆盖率和百日咳疾病报告阈值的规划效果。我们估计了不同水平的孕产妇疫苗接种覆盖率相对于反事实“未接种疫苗”情景的人群可预防比例(PFP)。我们模拟了免疫钝化的影响,并通过中断暴露途径来衡量保护效果。
在大多数模拟中,PVE与母体免疫产生的被动免疫持续时间呈负相关。在孕产妇疫苗接种覆盖率为50%的情况下,PVE为87%(95%分位数为82 - 91%),PFP为44%(95%分位数为41 - 45%)。对于0 - 2、2 - 4、4 - 6和6 - 12月龄的月度间隔,PVE在82%至99%之间,PFP在41%至49%之间。在孕产妇疫苗接种覆盖率为75%时,PVE和PFP分别为90%(95%分位数为86 - 92%)和68%(95%分位数为65 - 69%)。在孕产妇疫苗接种覆盖率为50%且钝化率为10%时,PVE和PFP分别为86%(95%分位数为77 - 87%)和43%(95%分位数为39 - 44%),而在钝化率为50%时,PVE和PFP的相应值分别为76%(95%分位数为70 - 81%)和38%(95%分位数为35 - 40%)。因暴露途径中断导致的PVE为54 - 57%。
我们的模型预测,由于孕产妇接种疫苗,未来婴儿百日咳病例将显著减少,免疫钝化会使其效果略有降低。该模型对孕产妇疫苗接种覆盖率最为敏感。暴露途径的中断在因孕产妇免疫而减轻婴儿百日咳负担方面发挥了作用。孕产妇免疫对婴儿以外人群的影响仍有待阐明。